U.S. FDA declines to approve Vanda's drug for stomach paralysis-January 2024-www.financetom.com

U.S. FDA declines to approve Vanda's drug for stomach paralysis

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

U.S. FDA declines to approve Vanda's drug for stomach paralysis

Sep 22, 2024 5:08 PM

Sept 19 (Reuters) - The U.S. Food and Drug

Administration has declined to approve Vanda Pharmaceuticals' ( VNDA )

drug for the treatment of symptoms of paralysis of the

stomach, the company said on Thursday.

(Reporting by Sriparna Roy in Bengaluru; Editing by Abinaya

Vijayaraghavan)

Previous page： First Solar Stock Sinks After Worse-Than-Expected Q3 Results, Cut FY24 Guidance Next page： W. P. Carey Q3 Adjusted FFO, Revenue Fall; 2024 Guidance Updated

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

First Solar Stock Sinks After Worse-Than-Expected Q3 Results, Cut FY24 Guidance

Nov 3, 2024

First Solar, Inc. ( FSLR ) reported its third-quarter results after Tuesday's closing bell. Here's a look at the key figures from the quarter. The Details: First Solar ( FSLR ) reported quarterly earnings of $2.91 per share, which missed the analyst consensus estimate of $3.13. The company said its earnings were impacted by a $50 million product warranty reserve...

W. P. Carey Q3 Adjusted FFO, Revenue Fall; 2024 Guidance Updated

Nov 3, 2024

05:11 PM EDT, 10/29/2024 (MT Newswires) -- W. P. Carey (WPC) reported Q3 adjusted funds from operations late Tuesday of $1.18 per diluted share, down from $1.32 a year earlier. Analysts polled by Capital IQ expected $1.17. Revenue in the quarter ended Sept. 30 fell to $397.4 million from $448.6 million a year earlier. Analysts surveyed by Capital IQ expected...

Unum Group Q3 Adjusted Earnings, Revenue Rise

Nov 3, 2024

05:10 PM EDT, 10/29/2024 (MT Newswires) -- Unum Group ( UNM ) reported Q3 adjusted operating income late Tuesday of $2.13 per share, up from $1.94 a year earlier. Analysts surveyed by Capital IQ expected $2.11. Revenue for the quarter ended Sept. 30 was $3.22 billion, up from $3.09 billion a year earlier. Analysts surveyed by Capital IQ expected $3.26...

Morguard North American Residential REIT Reports a Third-Quarter Loss

Nov 3, 2024

04:31 PM EDT, 10/29/2024 (MT Newswires) -- Morguard North American Residential REIT (MRC.TO, MRG-UN.TO) reported after close Tuesday a third quarter loss due to fair-value charges. The REIT said it lost of $18.8 million for the three months ended Sept. 30, a drop of of $58 million compared to 2023, predominantly due to a higher net fair value loss and...